Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials

BACKGROUND: Several ongoing phase 2 trials are evaluating new neoadjuvant therapy regimens in patients with muscle-invasive bladder cancer (MIBC). The 1-yr recurrence-free survival (RFS) after radical cystectomy (RC), with or without perioperative chemotherapy, can be used to model statistical assum...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Urol Oncol
Main Authors: Bandini, Marco, Briganti, Alberto, Plimack, Elizabeth R., Niegisch, Gunter, Yu, Evan Y., Bamias, Aristotelis, Agarwal, Neeraj, Sridhar, Srikala S., Sternberg, Cora N., Vaishampayan, Ulka, Theodore, Christine, Rosenberg, Jonathan E., Bellmunt, Joaquim, Galsky, Matthew D., Montorsi, Francesco, Necchi, Andrea
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552889/
https://ncbi.nlm.nih.gov/pubmed/31200838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euo.2018.08.009
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker